Verona Pharma plc (VRNA)
NASDAQ: VRNA · Real-Time Price · USD
93.82
-0.58 (-0.61%)
At close: Jun 27, 2025, 4:00 PM
93.40
-0.42 (-0.45%)
After-hours: Jun 27, 2025, 7:59 PM EDT
Verona Pharma Market Cap
Verona Pharma has a market cap or net worth of $8.55 billion as of June 27, 2025. Its market cap has increased by 733.68% in one year.
Market Cap
8.55B
Enterprise Value
8.39B
1-Year Change
733.68%
Ranking
Category
Stock Price
$93.82
Market Cap Chart
Since April 27, 2017, Verona Pharma's market cap has increased from $173.40M to $8.55B, an increase of 4,831.40%. That is a compound annual growth rate of 61.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 8.04B | 111.48% |
| Dec 31, 2024 | 3.80B | 139.13% |
| Dec 29, 2023 | 1.59B | -19.57% |
| Dec 30, 2022 | 1.98B | 389.96% |
| Dec 31, 2021 | 403.30M | 33.68% |
| Dec 31, 2020 | 301.70M | 298.55% |
| Dec 31, 2019 | 75.70M | -40.25% |
| Dec 31, 2018 | 126.70M | -16.92% |
| Dec 29, 2017 | 152.50M | -12.05% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 714.20B |
| Johnson & Johnson | 367.05B |
| AbbVie | 329.79B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 274.97B |
| Abbott Laboratories | 233.03B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |